These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 31945351)

  • 1. AGA Technical Review on the Management of Moderate to Severe Ulcerative Colitis.
    Singh S; Allegretti JR; Siddique SM; Terdiman JP
    Gastroenterology; 2020 Apr; 158(5):1465-1496.e17. PubMed ID: 31945351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AGA Technical Review on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.
    Singh S; Proctor D; Scott FI; Falck-Ytter Y; Feuerstein JD
    Gastroenterology; 2021 Jun; 160(7):2512-2556.e9. PubMed ID: 34051985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AGA Clinical Practice Guidelines on the Management of Moderate to Severe Ulcerative Colitis.
    Feuerstein JD; Isaacs KL; Schneider Y; Siddique SM; Falck-Ytter Y; Singh S;
    Gastroenterology; 2020 Apr; 158(5):1450-1461. PubMed ID: 31945371
    [No Abstract]   [Full Text] [Related]  

  • 4. AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis.
    Singh S; Feuerstein JD; Binion DG; Tremaine WJ
    Gastroenterology; 2019 Feb; 156(3):769-808.e29. PubMed ID: 30576642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical practice guidelines for the medical management of nonhospitalized ulcerative colitis: the Toronto consensus.
    Bressler B; Marshall JK; Bernstein CN; Bitton A; Jones J; Leontiadis GI; Panaccione R; Steinhart AH; Tse F; Feagan B;
    Gastroenterology; 2015 May; 148(5):1035-1058.e3. PubMed ID: 25747596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spotlight: Management of Moderate-to-Severe Ulcerative Colitis.
    Feuerstein JD; Isaacs KL; Schneider Y; Siddique SM; Falck-Ytter Y; Singh S;
    Gastroenterology; 2020 Apr; 158(5):1464. PubMed ID: 32169295
    [No Abstract]   [Full Text] [Related]  

  • 7. Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis.
    Hoffmann P; Wehling C; Krisam J; Pfeiffenberger J; Belling N; Gauss A
    World J Gastroenterol; 2019 Apr; 25(13):1603-1617. PubMed ID: 30983820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review.
    Damião AOMC; de Azevedo MFC; Carlos AS; Wada MY; Silva TVM; Feitosa FC
    World J Gastroenterol; 2019 Mar; 25(9):1142-1157. PubMed ID: 30863001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P074 Comparative Risk of Clostridioides Difficile Infection in Vedolizumab vs anti-TNFa Agents in Biologic-Naïve Patients With Ulcerative Colitis.
    Dalal R; Mitri J; Goodrick H; Allegretti J
    Am J Gastroenterol; 2021 Dec; 116(Suppl 1):S19. PubMed ID: 37461990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there room for immunomodulators in ulcerative colitis?
    Chhibba T; Ma C
    Expert Opin Biol Ther; 2020 Apr; 20(4):379-390. PubMed ID: 31874578
    [No Abstract]   [Full Text] [Related]  

  • 11. Systematic review with network meta-analysis: first- and second-line pharmacotherapy for moderate-severe ulcerative colitis.
    Singh S; Fumery M; Sandborn WJ; Murad MH
    Aliment Pharmacol Ther; 2018 Jan; 47(2):162-175. PubMed ID: 29205406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Management of Adult Outpatients With Moderate to Severely Active Ulcerative Colitis: Clinical Decision Support Tool.
    American Gastroenterological Association
    Gastroenterology; 2020 Apr; 158(5):1462-1463. PubMed ID: 32216899
    [No Abstract]   [Full Text] [Related]  

  • 13. Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents.
    Iborra M; Beltrán B; Maroto N; Navarro-Cortés P; Boscá-Watts M; Ferrer-Bradley I; García-Morales N; Sáez-González E; Hinojosa J; Mínguez M; Nos P
    Gastroenterol Hepatol; 2018 Nov; 41(9):535-543. PubMed ID: 30031573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tofacitinib Salvage Therapy for Children Hospitalized for Corticosteroid- and Biologic-Refractory Ulcerative Colitis.
    Constant BD; Baldassano R; Kirsch J; Mitchel EB; Stein R; Albenberg L
    J Pediatr Gastroenterol Nutr; 2022 Dec; 75(6):724-730. PubMed ID: 36122389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First- and Second-Line Pharmacotherapies for Patients With Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis.
    Singh S; Murad MH; Fumery M; Dulai PS; Sandborn WJ
    Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2179-2191.e6. PubMed ID: 31945470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the management of ulcerative colitis.
    Hoentjen F; Sakuraba A; Hanauer S
    Curr Gastroenterol Rep; 2011 Oct; 13(5):475-85. PubMed ID: 21789495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical management of left-sided ulcerative colitis and ulcerative proctitis: critical evaluation of therapeutic trials.
    Regueiro M; Loftus EV; Steinhart AH; Cohen RD
    Inflamm Bowel Dis; 2006 Oct; 12(10):979-94. PubMed ID: 17012969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic therapies for severe steroid refractory hospitalized ulcerative colitis: A network meta-analysis.
    Komaki Y; Komaki F; Micic D; Yamada A; Suzuki Y; Sakuraba A
    J Gastroenterol Hepatol; 2017 Jun; 32(6):1143-1151. PubMed ID: 27957761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current therapy of inflammatory bowel disease in children.
    Rufo PA; Bousvaros A
    Paediatr Drugs; 2006; 8(5):279-302. PubMed ID: 17037946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related Complications.
    Targownik LE; Benchimol EI; Bernstein CN; Singh H; Tennakoon A; Zubieta AA; Coward S; Jones J; Kaplan GG; Kuenzig ME; Murthy SK; Nguyen GC; Peña-Sánchez JN
    J Crohns Colitis; 2020 Oct; 14(10):1354-1363. PubMed ID: 32648579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.